Standard

ISPE ISPE Good Practice Guide: Harmonizing the Definition and Use of Non-Investigational Medicinal Products (NIMPs)

Publisert

Merknad: Denne standarden har en ny utgave: ISPE ISPE Good Practice Guide: Digital Validation

Forhåndsvisning Forhåndsvisning er ikke tilgjengelig
Dette produktet er ikke tilgjengelig for enkeltkjøp

Omfang

Recent survey results show that the pharmaceutical companies often take an overly conservative approach to NIMPs (or Non-IMPs) due to regulatory and operational ambiguity. This can lead to unnecessary expenses and process steps, which can needlessly complicate clinical trials. The ISPE Good Practice Guide: Harmonizing the Definition and Use of Non-Investigational Medicinal Products (NIMPs) aims to provide practical operational guidance and drive a consistent industry approach to the use of NIMPs. The Guide contains criteria for classifying NIMPs and an overview of current NIMP regulatory requirements. This in-depth Guide will help you properly manage NIMPs by providing guidance on: Sourcing strategies Packaging and labeling approaches Storage and distribution recommendations Regulations categorized by region/country Approaches to management of drug accountability, traceability, complaints and recalls with reference to the original sourcing strategy Regulatory differences between NIMPs and comparators

Dokumentinformasjon

  • Standard fra ISPE
  • Publisert:
  • Versjon: 0
  • Varetype: IS
  • Products.Specs.pages